简体中文 | 繁體中文 | English

Products & Services News

2024-10-09 11:21 NatsumeAtari to Exhibit at Global Gaming Expo (G2E) 2024, One of the World’s Largest Gaming Trade Shows
2024-10-09 11:14 Novaliq and Laboratoires Théa Announce Partnership and EU Approval for Vevizye® (Ciclosporin 0.1% Eye Drops Solution)
2024-10-09 09:59 Ferring Pharmaceuticals bolsters global gene therapy supply chain with European manufacturing facility
2024-10-09 09:54 Energy and Infrastructure Partner Kristian Bradshaw Joins Hunton Andrews Kurth in Tokyo
2024-10-09 09:51 Egon Zehnder Expands Canadian Footprint With New Vancouver Office
2024-10-09 09:26 Energy Vault Continues to Execute on Growth Strategy with Ownership of Energy Storage Projects and Launches Project Financing
2024-10-08 16:59 PUMA Explores Leather vs Vegan Leather With Global Goals Ambassador
2024-10-08 16:35 Arthur D. Little and Mathlabs Announce Strategic Partnership to Improve Open Innovation Outcomes Using AI
2024-10-08 16:19 Regnology Introduces Regnology Granular Data (RGD)
2024-10-08 16:16 Crown Bioscience Expands Singapore Facility with Advanced Oncology Models and Imaging Capabilities
2024-10-08 16:11 Digi International Unveils Digi 360, Transforming Cellular IoT Solutions for Seamless Management and Enhanced ROI
2024-10-08 15:57 Cancer Therapy: AOP Health Investigates a New Approach Targeting Cancer Stem Cells
2024-10-08 15:26 NetApp Expands Collaboration with Google Cloud to Provide Data Storage for Distributed Cloud Infrastructure
2024-10-08 15:22 RSA and Swissbit Announce New Phishing-Resistant Authentication Solution for Security-First Industries
2024-10-08 15:04 INVIDI Technologies Partners with Thaicom and PSI to Reinvent Thailand’s Media Industry
2024-10-08 14:56 Ferring Demonstrates Effectiveness of a Treat-to-Target Approach in Mild-to-Moderate Ulcerative Colitis in First Major Study
2024-10-08 14:43 SLB and ADNOC Drilling Partner for Unconventional Oil and Gas Development
2024-10-08 13:14 Copeland Unveils Unified Brand Identity Across Product Portfolio
2024-10-08 12:44 Crayon redefines cloud performance with breakthrough processor technology
2024-10-08 11:51 Primary Endpoint Met in Phase 3 Comparative Clinical Study of Perjeta® (pertuzumab) Biosimilar Candidate HLX11

Business Wire Weibo

Press Releases

Latest Releases